Allergan
vows limited price hikes, says ?outliers? deter research
(Reuters) – The chief executive ******r of
Allergan Plc said his company would limit annual
price increases on its prescription *****, and that “outlier” drugmakers that have imposed huge
price increases on their products were scaring off venture capital investors.
